SL-327
Catalog No. A14137
SL-327是MEK1和MEK2的选择性抑制剂(IC50值分别为0.18和0.22μM);在体外阻断海马LTP。全身性给药后,体内的脑渗透剂会阻止大鼠的恐惧条件和学习,并在小鼠中产生神经保护作用。
Catalog Num | A14137 |
---|---|
M. Wt | 335.4 |
Formula | C16H12F3N3S |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 305350-87-2 |
Synonyms | SL 327, SL327 |
SMILES | C1=CC=C(C(=C1)C(=C(N)SC2=CC=C(C=C2)N)C#N)C(F)(F)F |
SL-327是MEK1和MEK2的选择性抑制剂(IC50值分别为0.18和0.22μM);在体外阻断海马LTP。全身性给药后,体内的脑渗透剂会阻止大鼠的恐惧条件和学习,并在小鼠中产生神经保护作用。
Targets
Target | Value |
---|---|
MEK1 | IC50: 0.18μM |
MEK2 | IC50: 0.22μM |
AP-1 | IC50: 2.03μM |
PKC | IC50: >10μM |
MKK3/p38MAPK | IC50: 21μM |
ERK1 | IC50: >50μM |
MKK4 | IC50: >100μM |
JNK | IC50: >100μM |
In vitro (25°C) | DMSO | 66 mg/mL (196.81 mM) | |
Water | Insoluble | ||
Ethanol | 7 mg/mL (20.87 mM) | ||
In vivo | 2% DMSO+30% PEG 300+5% Tween 80+ddH2O | 4 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 29.82 mL | 149.08 mL | 298.15 mL |
0.5 mM | 5.96 mL | 29.82 mL | 59.63 mL |
1 mM | 2.98 mL | 14.91 mL | 29.82 mL |
5 mM | 0.6 mL | 2.98 mL | 5.96 mL |
*The above data is based on the productmolecular weight 335.4. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.